Page 112 - JSOM Summer 2023
P. 112

An Ongoing Series



                                            Tick-Borne Encephalitis

                            An Update for the Special Operations Forces Provider



                                                        1
                                                                                2
                                      Harpreet Kaur, MD ; Akira A. Shishido, MD *



          ABSTRACT
          Tick-borne encephalitis (TBE) is a severe disease caused by   providers should be aware of this disease entity and strongly
          the tick-borne encephalitis virus (TBEV).  TBEV is endemic   consider the newly FDA-approved TBE vaccine when planning
          throughout Eurasia and can cause persistent neurologic defi-  exercises and operations in  Areas of Responsibility (AORs)
          cits and death. Special Operations Forces (SOF) participating   with TBE-endemic countries.
          in field exercises or operations in TBE-endemic countries are
          at significantly increased risk of infection. Unlike Lyme disease   Military History
          and other tick-borne illnesses, transmission of TBEV can be
          immediate, and early tick removal does not reduce the risk of   TBE was first described in  Austria in 1931 with the caus-
          infection. While there are no virus-specific treatments avail-  ative agent later isolated in Russia in 1937. Since that time,
                                                                                                3
          able, the US Food and Drug Administration (FDA) recently   TBE has been documented across Eurasia, including many
          approved a TBE vaccine that has yet to be incorporated into   countries  housing US troops and DoD beneficiaries.  A  re-
                                                                                                       4
          formal Department of Defense (DoD) recommendations. SOF   cent retrospective analysis found eight cases of TBE among
          medical providers should be aware of this disease entity and   servicemembers and their beneficiaries stationed in Germany
          consider the TBE vaccine when planning exercises and oper-  between 2006 and 2018.  Of these eight cases, seven occurred
                                                                                4
          ations in areas of responsibility (AORs) with  TBE-endemic   in 2017 or 2018, suggesting an increasing rate of infection. A
          countries. This review serves as a refresher and update on the   case report describing three of these infections (a 26-year-old
          epidemiology, transmission, and management of TBE for the   male Soldier, a 17-year-old male dependent, and a 7-year-old
          SOF provider.                                      female dependent) found that while all three survived, all had
                                                             persistent headaches and cognitive complaints 3–6 months af-
          Keywords: Tick-borne encephalitis; tick-borne disease; vec-  ter diagnosis.  An updated survey described four additional
                                                                       4,5
          tor; biphasic; vaccines; biodefense                cases among Military Health System (MHS) beneficiaries
                                                             from 2019–2021, three of whom were active duty stationed
                                                             in Germany.   These observations are consistent with large-
                                                                       5
                                                             scale studies suggesting a growing number of reported cases
          Introduction
                                                             overall and that a significant percentage of TBE cases result
          Tick-borne encephalitis (TBE) is a severe vaccine-preventable   in long-term neurologic sequelae. There is likely a paucity of
                                                                                       1
          disease caused by tick-borne encephalitis virus (TBEV) trans-  data describing the burden of disease among temporary duty
          mitted by  Ixodes species ticks.   TBEV is among the most   (TDY) personnel. While TBE has been a recognized threat to
                                   1
          prevalent causes of arthropod-borne viral meningitis and en-  force health protection for decades, US servicemembers had no
          cephalitis worldwide.  Many cases of TBE result in persistent   FDA-approved vaccine options until 2021.
                           1,2
          neurologic deficits, and case fatality rates can exceed 20%.
                                                         2
          Servicemembers, particularly Special Operations Forces (SOF)   Epidemiology/Transmission
          participating in field exercises or operations in TBE-endemic
          countries, are at significantly increased risk of infection. Mea-  TBE is endemic to countries across the Eurasian continent
          sures to prevent tick bites include standard insect precautions   where the Ixodes tick vectors are present, creating the “TBE
          (including  use  of  repellents,  long  sleeves,  permethrin-treated   Belt” (Figure 1). The virus circulates between ticks and vari-
          clothing, bed netting, and other gear). However, unlike Lyme   ous reservoirs: ruminants, birds, rodents, horses, and humans
          disease and other tick-borne illnesses, transmission of TBEV   (Figure 2). Three viral subtypes from the family Flaviviridae
          from a tick bite can be immediate, and early tick removal   (genus Flavivirus) cause TBE: Siberian (TBEV-Sib), Far Eastern
          does not reduce risk of infection.  Given TBE’s potential for   (TBEV-FE), and Western (TBEV-Eu). The vector for TBEV-Eu
                                    1
          significant morbidity and efficient transmission, SOF medical   is Ixodes Ricinus (Western, Central, and Eastern Europe). The
          *Correspondence to akira.shishido@vcuhealth.org
          1 Dr Harpreet Kaur is a physician affiliated with the University of Maryland Medical Center Division of Infectious Diseases, Baltimore, MD.
          2 Dr Akira A. Shishido is a physician affiliated with Virginia Commonwealth University, Division of Infectious Diseases, Richmond, VA.

                                                          110
                                                          110
   107   108   109   110   111   112   113   114   115   116   117